Frontage Opens New Lab Facility in Exton, PA
Frontage Laboratories, Inc. completed construction of a new 71,000 sq.-ft. laboratory facility in Exton, PA.
August 10, 2021
by contractpharma
Frontage to Acquire Quintara Discovery
Quintara provides in vitro ADME profiling, bioanalytical services, and dedicated assay development and compound screening.
July 2, 2021
by contractpharma
Frontage Laboratories Appoints Executive Director, Regional Head of Sales, West
John Foster will be accountable for overseeing business development efforts in the western US.
May 6, 2021
by contractpharma
Frontage Acquires Ocean Ridge Biosciences
Frontage Laboratories, Inc., has expanded its genomic services through the acquisition of Ocean Ridge Biosciences.
April 22, 2021
by contractpharma
Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ
Frontage Laboratories and Frontage Clinical Services have developed the capability to perform full-service human Absorption, Metabolism, and Excretion (hAME) studies with radiolabeled compounds at our clinical site in Secaucus, NJ.
April 12, 2021
by contractpharma
Frontage Acquires ACME Bioscience
Expands synthetic and medicinal chemistry and process research and development services.
July 9, 2020
by contractpharma
Frontage Clinical Expands NJ Facilities
Frontage Clinical Services, an associate of Frontage Laboratories, has completed renovations to Frontage Clinical’s center in Secaucus, NJ, to now accommodate clinical studies on tobacco and nicotine-containing products.
August 15, 2019
by contractpharma
Frontage Holdings Completes IPO
Proceeds from the global offering will be used to further expand the company's product development services capacity and capabilities.
June 10, 2019
by contractpharma
Frontage Names Sridhar Krishnan SVP Global Operations
Will be responsible for integrating business units and provide operational excellence leadership across the Frontage organization.
May 16, 2019
by contractpharma